Original Research
Published on 11 Sep 2024
Development of transcriptomic tools for predicting the response to individual drug of the mFOLFIRINOX regimen in patients with metastatic pancreatic cancer
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1437200
- 3,593 views
- 8 citations

